Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02740465 · ClinicalTrials.gov registry record · NA
Anxiety and COPD Evaluation
A NA study of Chronic Obstructive Pulmonary Disease, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT02740465 is a NA study of Chronic Obstructive Pulmonary Disease that has completed, run by NYU Langone Health. The registered enrollment target is 200 participants, below the 1,752-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02740465, a NA study of Chronic Obstructive Pulmonary Disease, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective, multicenter, cohort study is designed to validate Anxiety Inventory Respiratory Disease questionnaire in patients with Chronic Obstructive Pulmonary Disease (COPD). The primary purpose of this study is to assess the validity of the Anxiety Inventory Respiratory (AIR) scale in detecting anxiety in relation to the DSM-V criteria in patients with COPD. * To evaluate associations between COPD symptom scores assessed by the CAT questionnaire and MMRC dyspnea scale and measures of depression and anxiety * To evaluate associations between physiologic measures of lung function (spirometry) and exercise tolerance (6 minute walk) and measures of depression and anxiety * To evaluate associations between exacerbations of COPD and the prevalence of anxiety and depression in a cohort of COPD patients
Conditions Studied
Interventions
- BEHAVIORAL Hospital Anxiety and Depression Scale (HADS)
- BEHAVIORAL Anxiety Inventory for Respiratory Disease (AIR)
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2016-01 |
| Est. Completion | 2019-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02740465
The ClinicalTrials.gov registry entry for NCT02740465 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,752-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (89% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 2 interventions - of which Hospital Anxiety and Depression Scale (HADS) is the first listed.
NCT02740465 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02740465 about?
NCT02740465 is a clinical study titled "Anxiety and COPD Evaluation". This prospective, multicenter, cohort study is designed to validate Anxiety Inventory Respiratory Disease questionnaire in patients with Chronic Obstructive Pulmonary Disease (COPD). The primary purpose of this study is to assess the validity of the Anxiety Inventory Respiratory (AIR) scale in dete...
What is the current status of trial NCT02740465?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2016-01. Estimated completion is 2019-03-01.
What conditions does trial NCT02740465 study?
This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease.
What interventions are being tested in trial NCT02740465?
The interventions under investigation include: Hospital Anxiety and Depression Scale (HADS) (BEHAVIORAL), Anxiety Inventory for Respiratory Disease (AIR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02740465?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02740465 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Obstructive Pulmonary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
RECRUITING · NA
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
RECRUITING · NA
-
Improving Participation in Pulmonary Rehabilitation Through Peer Support and Storytelling
RECRUITING · NA
-
PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
RECRUITING · NA
-
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.